← back to search

Constance Baer

Munich Leukemia Laboratory (Germany) · DE
Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, and MicroRNA in disease regulation.
h-index
26
citations
3,239
works
170
NIH funding
primary concept
Medicine
email

Recent publications

2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party
Blood 2025cited by 16position: middledoi
The clinical and genomic landscape of patients with <i>DDX41</i> variants identified during diagnostic sequencing
Blood Advances 2023cited by 26position: middledoi
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022
Blood 2023cited by 20position: middledoi
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
Blood 2021cited by 703position: middledoi
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
Blood 2020cited by 129position: middledoi
Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma
Epigenetics 2016cited by 43position: middledoi
Prognostic relevance of miRNA-155 methylation in anaplastic glioma
Oncotarget 2016cited by 25position: middledoi
Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia
International Journal of Cancer 2015cited by 58position: firstdoi
Oncogenic role of <scp>miR</scp>‐155 in anaplastic large cell lymphoma lacking the t(2;5) translocation
The Journal of Pathology 2015cited by 53position: middledoi
Methylome screen identifies epigenetically deregulated microRNAs in cholangiocarcinoma
Zeitschrift für Gastroenterologie 2015cited by 0position: middledoi
BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence
Nature Genetics 2014cited by 151position: middledoi
Aberrant DNA Methylation
Elsevier eBooks 2014cited by 5position: firstdoi
Abstract 3043: Mesenchymal phenoptype of metastasizing primary human colorectal TIC is maintained through epigenetic silencing of miR-200
Cancer Research 2014cited by 0position: middledoi
Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
Cancer Cell 2013cited by 325position: middledoi
Genome-Wide Epigenetic Regulation of miRNAs in Cancer
Cancer Research 2013cited by 296position: firstdoi
Abstract B42: An integrated view on genetic and epigenetic mechanisms revealed aberrant DNA methylation as an important source for miRNA deregulation in prostate cancer
Cancer Research 2013cited by 0position: middledoi
Extensive Promoter DNA Hypermethylation and Hypomethylation Is Associated with Aberrant MicroRNA Expression in Chronic Lymphocytic Leukemia
Cancer Research 2012cited by 134position: firstdoi
Enrichment of Methylated DNA by Methyl-CpG Immunoprecipitation
Methods in molecular biology 2012cited by 27position: middledoi
Abstract B10: Genome-wide profiling reveals hyper- and hypomethylation at microRNA promoters in chronic lymphocytic leukemia
Cancer Research 2012cited by 0position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Christoph Plass · German Cancer Research Center10 papers (2012–2016)Dieter Weichenhan · German Cancer Research Center6 papers (2012–2016)Rainer Claus · Molecular Oncology (United States)4 papers (2012–2015)Michael Rehli · University Hospital Regensburg3 papers (2012–2012)Wilko Weichert · German Cancer Research Center3 papers (2014–2016)Lei Gu · Ningbo Medical Center Lihuili Hospital3 papers (2012–2013)Torsten Haferlach · Martin Luther Christian University2 papers (2023–2023)Christopher C. Oakes · The Ohio State University2 papers (2014–2015)Wolfgang Kern · University Hospital Leipzig2 papers (2023–2023)Christian P. Pallasch · Integrated Oncology (United States)2 papers (2012–2012)Piers Blombery · Peter MacCallum Cancer Centre2 papers (2023–2023)Yoon Jung Park · Ewha Womans University2 papers (2012–2012) · 2 papers (2023–2023)Ruprecht Kuner · German Cancer Research Center2 papers (2013–2014)Lukas P. Frenzel · Klinik und Poliklinik für Psychosomatik und Psychotherapie2 papers (2012–2012)Stephan Hütter · Munich Leukemia Laboratory (Germany)2 papers (2023–2023)Manuela Zucknick · Oslo University Hospital2 papers (2012–2012)Peter Schirmacher · Kliniken Essen-Mitte2 papers (2015–2016)Ronald Simon · Universität Hamburg2 papers (2013–2014)Arne Warth · Heidelberg University2 papers (2015–2016)